https://www.selleckchem.com/pr....oducts/l-alpha-phosp
001). Thirty-day mortality was significantly higher in the no-IDC group (27 % vs 12 %; P less then .007). In multivariate analysis, 30-day in-hospital mortality was associated with both E. faecium bacteremia (adjusted odds ratio [aOR], 2.39; 95% confidence interval [CI], 1.09-5.23) and IDC (aOR, 0.35; 95% CI, 0.16-0.76). Conclusions Patients who received IDC for Enterococcus bacteremia had significantly lower 30-day mortality. Further prospective studies are necessary to determine if these outcomes can be validated
Like
Comment
Share
